Correlation between Serum PSA Level & AMACR Expression in Prostatic Cancer
Prostate cancer is the second most common cause of cancer and the sixth leading cause of cancer death among men worldwide. To diagnose prostate cancer, no specific single histological feature is sufficiently available. A positive diagnostic marker specific for prostatic adenocarcinoma may enhance the ability to detect small foci of cancer and reduce diagnostic difficulties. This study focuses on correlation between serum PSA level and AMACR (a proven biomarker) expression in prostate cancer.
Institutions
- University of Medicine Tirana (AL)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2025-07-13
- DOI
- https://doi.org/10.5281/zenodo.15872865
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00